Day: May 8, 2025

Runway Growth Finance Corp. Announces Second Quarter Regular Dividend of $0.33 and $0.02 Supplemental Distribution

Written by Customer Service on May 8, 2025. Posted in Dividend Reports And Estimates.

MENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that its Board of Directors has declared a second quarter 2025 regular cash distribution of $0.33 per share. In addition, the Board of Directors declared a supplemental dividend of $0.02 per share, for the second quarter of 2025. The following shows the key dates of the second quarter 2025 dividend, including the supplemental dividend: Declaration Date: May 7, 2025Record Date: May 19, 2025Payment Date: June 3, 2025 Runway Growth generally intends to distribute, out of assets legally available for distribution, substantially all of its available earnings, on a...

Red Cat to Report Q1 2025 Earnings and Provide Corporate Update on Wednesday, May 14, 2025

Written by Customer Service on May 8, 2025. Posted in Public Companies.

Conference Call to be held Wednesday, May 14, 2025 at 4:30 p.m. Eastern Time SAN JUAN, Puerto Rico, May 08, 2025 (GLOBE NEWSWIRE) — Red Cat (Nasdaq: RCAT) (“Red Cat” or the “Company”), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, announces that financial results for the Q1 2025 period will be reported on Wednesday, May 14, 2025 at the market close. Company management will host an earnings conference call at 4:30p.m. ET on Wednesday, May 14, 2025 to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session. Interested parties can listen to the conference call by dialing 1-844-413-3977 (within the U.S.) or 1-412-317-1803 (international)....

EXL to participate in upcoming investor conferences

Written by Customer Service on May 8, 2025. Posted in Public Companies.

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) — ExlService Holdings, Inc. (NASDAQ: EXLS), a leading data and AI company, today announced Maurizio Nicolelli, executive vice president, chief financial officer, and John Kristoff, vice president, head investor relations, are expected to participate at the following investor conferences:20th Annual Needham Technology, Media, & Consumer 1×1 Conference, Monday, May 12, 2025, Virtual TD Cowen 53nd Annual Technology, Media & Telecom Conference, Thursday, May 29, 2025, New York, NY, (presentation at 10:50 AM EDT) Baird 2025 Global Consumer, Technology & Services Conference, Thursday, June 5, 2025, New York, NY (presentation at 2:00 PM EDT) Live audio webcasts of company presentations will available on the events page of EXL’s investor website.About ExlService Holdings,...

GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)

Written by Customer Service on May 8, 2025. Posted in Public Companies.

The Independent Data Monitoring Committee (IDMC) has recommended to continue the study as planned as there are no safety concerns seen in the data reviewed Continued momentum with completed patient enrollment for the 6-week interim analysis (N=24) and over two-thirds enrollment completed for the overall trial Results on track for interim data in Q2 2025 and topline data in Q3 2025 Management releases “What This Means” segment discussing the interim biomarker data; Access Here LA JOLLA, CA, May 08, 2025 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today reported interim biomarker results from its ongoing Phase 2a study evaluating...

Springbig Expands Executive Team with Strategic Hires to Drive Next Phase of Growth

Written by Customer Service on May 8, 2025. Posted in Public Companies.

BOCA RATON, Fla., May 08, 2025 (GLOBE NEWSWIRE) — Springbig (OTCQB: SBIG), a leading provider of marketing automation software and customer loyalty solutions, is excited to announce the addition of three seasoned executives to its leadership team. These strategic hires reflect the company’s commitment to continued growth, innovation, and operational excellence as it scales its SaaS platform and services across North America. Springbig also recently announced that Jaret Christopher has joined the company as its new CEO & President and has been appointed to its Board of Directors. Jaret is a highly accomplished technology entrepreneur with over 25 years of experience building high-growth vertical SaaS companies. He has led multiple successful exits, including transactions to WM Technology, Ellie Mae (acquired by Thoma Bravo),...

AIM ImmunoTech Announces the Presentation of Ampligen Oncology Data at the Recent Annual Meeting of the American Association of Immunologists

Written by Customer Service on May 8, 2025. Posted in Public Companies.

OCALA, Fla., May 08, 2025 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (OTC Pink: AIMI) (“AIM” or the “Company”) today announced the presentation of clinical trial data involving AIM’s drug Ampligen by Pawel Kalinski, MD, PhD, at the recent Annual Meeting of the American Association of Immunologists held May 3-7, 2025, in Honolulu, HI. The paper, titled “Systemic Infusion of dsRNA (Rintatolimod) plus IFN Promotes Selective Influx of CTLs (but not Treg) into the TME — Counteracting Chemokine Heterogeneity of the TME,” discussed the unique two-level selectivity of action of Ampligen when used as a part of chemokine modulation and combined with PD-1 blockade or chemotherapy. Dr. Kalinski discussed the preclinical data and data from recently completed clinical trials showing the ability of Ampligen to selectively induce...

Star Bulk Announces Date for the Release of First Quarter Ended March 31, 2025, Results, Conference Call, and Webcast

Written by Customer Service on May 8, 2025. Posted in Public Companies.

ATHENS, Greece, May 08, 2025 (GLOBE NEWSWIRE) — Star Bulk Carriers Corp. (the “Company” or “Star Bulk”) (Nasdaq: SBLK), today announced that it will release its results for the first quarter ended March 31, 2025, after the market closes in New York on Wednesday, May 14, 2025. Star Bulk’s management team will host a conference call to discuss the Company’s financial results on Thursday, May 15, 2025, at 11:00 a.m. Eastern Time (ET). Conference Call details: Participants should dial into the call 10 minutes before the scheduled time using the following numbers: +1 877 405 1226 (US Toll-Free Dial In) or +1 201 689 7823 (US and Standard International Dial In), or +0 800 756 3429 (UK Toll Free Dial In). Please quote “Star Bulk Carriers” to the operator and/or conference ID 13753831. Click here for...

AgEagle Aerial Systems Secures Additional Sale of eBee VISION Drones to the British Antarctic Survey

Written by Customer Service on May 8, 2025. Posted in Public Companies.

World leader in polar science and polar operations research to use additional drones to enhance its Antarctic conservation, research, and wildlife preservation efforts WICHITA, Kan., May 08, 2025 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of best-in-class unmanned aerial systems (UAS) and sensors for military, public safety, and commercial use, has sold two additional eBee VISION drones to the British Antarctic Survey (BAS), a world leader in polar science and polar operations. The BAS is part of the Natural Environment Research Council (NERC), an organization which supports the UK’s research activity in polar regions. NERC personnel conducting field work in some of the most extreme environments in the world will continue to rely on AgEagle drones to execute their research missions. “The eBee...

GAMCO Investors, Inc. Reports Results for the First Quarter 2025

Written by Customer Service on May 8, 2025. Posted in Earnings Releases And Operating Results.

Quarter End AUM of $31.2 billion Operating Margin of 32.4% for the First Quarter First Quarter Earnings of $0.81 per Share versus $0.64 per Share in the First Quarter of 2024 $175.4 million in Cash, Cash Equivalents, Seed Capital, and Investments, and No Debt Entered Partnership with Keeley on May 1st of 4 Open-End Funds and ~500 Separately Managed Accounts from Keeley-Teton, Adding Close to $1.0 billion in AUM Opened an office in Zurich, SwitzerlandGREENWICH, Conn., May 08, 2025 (GLOBE NEWSWIRE) — GAMCO Investors, Inc. (“Gabelli”) (OTCQX: GAMI) today reported its operating results for the quarter ended March 31, 2025. Financial Highlights(In thousands, except percentages and per share data) Three Months Ended March 31, 2025 December 31, 2024 March 31, 2024 U.S. GAAP Revenue $ 57,328 $ 59,262 $ 56,945 Expenses 38,735 42,130 41,597 Operating...

Transom Capital-Backed Secur-Serv Acquires Micro-Data Systems

Written by Customer Service on May 8, 2025. Posted in Mergers And Acquisitions.

Acquisition Fuels Growth of Managed IT Service Offerings and Expands Geographic Reach LOS ANGELES, May 08, 2025 (GLOBE NEWSWIRE) — Secur-Serv (www.secur-serv.com), a market-leading managed services provider backed by Transom Capital Group, announced it has completed the acquisition of Micro-Data Systems (https://mdsmsp.com/), a New Jersey-based managed service provider. This transaction marks another significant milestone in the expansion of Secur-Serv’s managed IT services offerings and is the company’s third acquisition in the last 12 months. Micro-Data Systems brings a robust portfolio of recurring services and a well aligned technology stack, ensuring seamless integration with Secur-Serv’s operations. With the recent onboarding of numerous new clients, this acquisition enhances Secur-Serv’s ability to scale and cross-sell complementary...

Day: May 8, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals